Acorda Therapeutics Higher Off Favorable Patent Ruling Related To Ampyra

By: via Benzinga
Acorda Therapeutics Inc (NASDAQ: ACOR) shares are trading higher by $1.83 (6.7 percent) at $30.13 in Thursday's session. At 2:47 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.